NCT00533650
Completed
Phase 2
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
ConditionsPost-Menopausal Osteoporosis
DrugsMK0429
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Post-Menopausal Osteoporosis
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 227
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
A study to asses the safety and efficacy of MK0429 in postmenopausal women with osteoporosis.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Person is a women with osteoporosis who is unwilling or unable to take other treatments for osteoporosis
Exclusion Criteria
- •Person has had a previous fracture
- •Person has rheumatoid arthritis. Person has has certain types of cancer
- •Person has donated blood or has been in another investigational study within the last 4 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast CancerPostmenopausal Bone LossBreast CancerNCT00399321University of Michigan Rogel Cancer Center9
Completed
Phase 3
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm AssessmentBreast CancerNCT00122356Barwon Health303
Completed
Phase 3
Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone LossOsteoporosisNCT00004650National Institute of Dental and Craniofacial Research (NIDCR)150
Enrolling By Invitation
Phase 4
Osteoporosis in Primary HyperparathyroidismPrimary HyperparathyroidismOsteoporosisNCT04085419University Medical Centre Ljubljana40
Completed
Phase 3
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis WomenPostmenopausal OsteoporosisNCT00165698Eisai Co., Ltd.240